{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:10:09Z","timestamp":1687954209767},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/bf03261916","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T01:19:02Z","timestamp":1357262342000},"page":"613-619","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Antipsoriatic Effect and Tolerability of Calcipotriol-Containing Products in the Treatment of Psoriasis Vulgaris Using a Modified Psoriasis Plaque Test"],"prefix":"10.1007","volume":"32","author":[{"given":"Catherine","family":"Queille-Roussel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Ganslandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus Krog","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"issue":"9583","key":"1916_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"C.E.M. Griffiths","year":"2007","unstructured":"Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370(9583): 263\u201371","journal-title":"Lancet"},{"issue":"1","key":"1916_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2340\/00015555524348","volume":"52","author":"K.J. Dumas","year":"1972","unstructured":"Dumas KJ, Scholtz JR. The psoriasis bio-assay for topical corticosteroid activity. Acta Derm Venereol 1972; 52(1): 43\u20138","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1916_CR3","first-page":"15","volume":"11","author":"M. Katz","year":"2000","unstructured":"Katz M, Shaikh Z, Maibach HI. Scholtz-Dumas psoriasis small plaque bioassay. J Dermatol Treat 2000; 11(1): 15\u20139","journal-title":"J Dermatol Treat"},{"key":"1916_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-7-107","volume":"7","author":"P.H. Kvist","year":"2009","unstructured":"Kvist PH, Svensson L, Hagberg O, et al. Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model. J Transl Med 2009; 7: 107","journal-title":"J Transl Med"},{"issue":"6","key":"1916_CR5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2133.2004.05986.x","volume":"150","author":"K. Kragballe","year":"2004","unstructured":"Kragballe K, Noerrelund KL, Lui H, et al. Efficacy of once-daily treatment regimens with calcipotriol\/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004; 150(6): 1167\u201373","journal-title":"Br J Dermatol"},{"issue":"2","key":"1916_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2133.2002.04967.x","volume":"147","author":"L. Guenther","year":"2002","unstructured":"Guenther L, Van de Kerkhof PC, Snellman E, et al. Efficacy and safety of a new combination of calcipotriol and beta-methasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002; 147(2): 316\u201323","journal-title":"Br J Dermatol"},{"issue":"4","key":"1916_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","volume":"205","author":"R. Kaufmann","year":"2002","unstructured":"Kaufmann R, Bibby AJ, Bissonnette R, et al. A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002; 205(4): 389\u201393","journal-title":"Dermatology"},{"issue":"4","key":"1916_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1684\/ejd.2010.0948","volume":"20","author":"C. Fleming","year":"2010","unstructured":"Fleming C, Ganslandt C, Guenther L, et al. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study. Eur J Dermatol 2010; 20(4): 465\u201371","journal-title":"Eur J Dermatol"},{"issue":"2","key":"1916_CR9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000323408","volume":"222","author":"R.G. Langley","year":"2011","unstructured":"Langley RG, Gupta A, Papp K, et al. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomised, controlled clinical trial. Dermatology 2011; 222(2): 148\u201356","journal-title":"Dermatology"},{"issue":"5","key":"1916_CR10","first-page":"585","volume":"20","author":"J.P. Ortonne","year":"2010","unstructured":"Ortonne JP, Noerrelund KL, Papp K, et al. Comparison of two different dose combinations of calcipotriol\/hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body. Eur J Dermatol 2010; 20(5): 585\u20139","journal-title":"Eur J Dermatol"},{"issue":"6","key":"1916_CR11","first-page":"570","volume":"8","author":"A.H. Zivkovich","year":"2009","unstructured":"Zivkovich AH, Feldman SR. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol 2009; 8(6): 570\u20132","journal-title":"J Drugs Dermatol"},{"key":"1916_CR12","first-page":"573","volume-title":"European study into the opinions of psoriasis patients and physicians","author":"K. Hol","year":"2010","unstructured":"Hol K. European study into the opinions of psoriasis patients and physicians. 19th Congress of the European Academy of Dermatology and Venereology (EADV), 6\u201310 October 2010, Gothenburg, Sweden; p. 573"},{"key":"1916_CR13","first-page":"572","volume-title":"Patient preference for topical psoriasis formulations","author":"K. Hol","year":"2010","unstructured":"Hol K. Patient preference for topical psoriasis formulations. 19th Congress of the European Academy of Dermatology and Venereology (EADV), 6\u201310 October 2010, Gothenburg, Sweden; p. 572"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03261916\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:33:05Z","timestamp":1687951985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03261916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1007\/bf03261916","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}